Overview
Observational prospective study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the iniation of triple inhaled formoterol/glycopyrrolate/budesonide therapy.
Description
The purpose of the trixeo study is to conduct a prospective observational study to evaluate serum NT-proBNP levels in a population of COPD patients three months after the initiation of triple inhaled formoterol/glycopyrrolate/budesonide therapy.
Eligibility
Inclusion Criteria:
- COPD;
- Clinical indication for triple inhalation therapy with formoterol/glycopyrrolate/budesonide;
Exclusion Criteria:
- Life expectancy less than one year;